002821 凯莱英
已收盘 01-20 15:00:00
资讯
新帖
简况
Norges Bank减持凯莱英(06821)11万股 每股作价约88.2港元
智通财经网 · 01-19 19:08
Norges Bank减持凯莱英(06821)11万股 每股作价约88.2港元
股市必读:凯莱英(002821)1月16日董秘有最新回复
证券之星 · 01-19 01:28
股市必读:凯莱英(002821)1月16日董秘有最新回复
Schroders PLC减持凯莱英(06821)16.77万股 每股作价约83.63港元
智通财经 · 01-13
Schroders PLC减持凯莱英(06821)16.77万股 每股作价约83.63港元
凯莱英遭Schroders PLC减持26.05万股 每股作价约82.71港元
新浪港股 · 01-11
凯莱英遭Schroders PLC减持26.05万股 每股作价约82.71港元
Schroders PLC减持凯莱英(06821)26.05万股 每股作价约82.71港元
智通财经网 · 01-09
Schroders PLC减持凯莱英(06821)26.05万股 每股作价约82.71港元
凯莱英(002821)披露证券变动月报表,1月5日股价上涨3.17%
证券之星 · 01-05
凯莱英(002821)披露证券变动月报表,1月5日股价上涨3.17%
凯莱英:多肽项目进入中后期后对产能需求高
证券之星 · 2025-12-31
凯莱英:多肽项目进入中后期后对产能需求高
凯莱英:天津新产能匹配新业务领域
证券之星 · 2025-12-31
凯莱英:天津新产能匹配新业务领域
深市“双提升”:471家率先行动,分红占净利润比重2年提升近11个百分点
第一财经 · 2025-12-27
深市“双提升”:471家率先行动,分红占净利润比重2年提升近11个百分点
股市必读:凯莱英(002821)12月22日董秘有最新回复
证券之星 · 2025-12-23
股市必读:凯莱英(002821)12月22日董秘有最新回复
凯莱英(06821)将购回及注销3.3万股受限制A股股份
智通财经 · 2025-12-19
凯莱英(06821)将购回及注销3.3万股受限制A股股份
医药股今早显著反弹 凯莱英及药明生物均涨超6%
新浪港股 · 2025-12-19
医药股今早显著反弹 凯莱英及药明生物均涨超6%
港股异动 | 凯莱英(06821)午前涨近3% 近期凯莱英生物上海奉贤基地正式投产 重点布局联药物NDCs等领域
智通财经 · 2025-12-08
港股异动 | 凯莱英(06821)午前涨近3% 近期凯莱英生物上海奉贤基地正式投产 重点布局联药物NDCs等领域
凯莱英(002821)披露A股股权激励股份转让进展,12月2日股价下跌2.06%
证券之星 · 2025-12-02
凯莱英(002821)披露A股股权激励股份转让进展,12月2日股价下跌2.06%
凯莱英(06821)授出29.14万股A股限制性股票
智通财经网 · 2025-11-27
凯莱英(06821)授出29.14万股A股限制性股票
凯莱英:持续技术创新保障业务增长
证券之星 · 2025-11-27
凯莱英:持续技术创新保障业务增长
摩根大通减持凯莱英(06821)7.07万股 每股作价约84.7港元
智通财经 · 2025-11-18
摩根大通减持凯莱英(06821)7.07万股 每股作价约84.7港元
摩根大通增持凯莱英(06821)6.19万股 每股均价约83.89港元
智通财经网 · 2025-11-13
摩根大通增持凯莱英(06821)6.19万股 每股均价约83.89港元
Norges Bank增持凯莱英(06821)6.52万股 每股作价约84.39港元
智通财经网 · 2025-11-11
Norges Bank增持凯莱英(06821)6.52万股 每股作价约84.39港元
凯莱英遭摩根大通减持20.2万股 每股作价约83.43港元
新浪港股 · 2025-11-10
凯莱英遭摩根大通减持20.2万股 每股作价约83.43港元
加载更多
公司概况
公司名称:
凯莱英医药集团(天津)股份有限公司
所属行业:
医药制造业
上市日期:
2016-11-18
主营业务:
凯莱英医药集团(天津)股份有限公司的主营业务是为国内外制药公司、生物技术公司提供药品全生命周期的一站式服务。公司的主要产品是临床阶段CDMO解决方案、商业化阶段CDMO解决方案、新兴服务。截至报告期末公司共有国内外已授权专利538项,其中国内专利423项,国外专利115项,其中183项在合成生物领域,204项在连续反应技术领域。
发行价格:
30.53
{"stockData":{"symbol":"002821","market":"SZ","secType":"STK","nameCN":"凯莱英","latestPrice":103.2,"timestamp":1768892619000,"preClose":103.95,"halted":0,"volume":4598497,"delay":0,"changeRate":-0.0072,"floatShares":317000000,"shares":361000000,"eps":2.881,"marketStatus":"已收盘","change":-0.75,"latestTime":"01-20 15:00:00","open":103.94,"high":104.66,"low":101.31,"amount":471000000,"amplitude":0.0322,"askPrice":103.2,"askSize":60,"bidPrice":103.19,"bidSize":1,"shortable":0,"etf":0,"ttmEps":2.881,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1768959000000},"marketStatusCode":5,"adr":0,"adjPreClose":103.95,"symbolType":"stock","openAndCloseTimeList":[[1768872600000,1768879800000],[1768885200000,1768892400000]],"highLimit":114.35,"lowLimit":93.56,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":360593720,"isCdr":false,"pbRate":2.16,"roa":"--","peRate":35.820896,"roe":"4.63%","epsLYR":2.69,"committee":-0.953353,"marketValue":37213000000,"turnoverRate":0.0145,"status":1,"hkstockBrief":{"symbol":"06821","market":"HK","secType":"STK","nameCN":"凯莱英","latestPrice":84,"timestamp":1768896484007,"preClose":86.75,"halted":0,"volume":195800,"delay":0,"premium":"-27.41"},"floatMarketCap":32714000000},"requestUrl":"/m/hq/s/002821","defaultTab":"news","newsList":[{"id":"2604013818","title":"Norges Bank减持凯莱英(06821)11万股 每股作价约88.2港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2604013818","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604013818?lang=zh_cn&edition=full","pubTime":"2026-01-19 19:08","pubTimestamp":1768820899,"startTime":"0","endTime":"0","summary":"香港联交所最新资料显示,1月14日,Norges Bank减持凯莱英(06821)11万股,每股作价88.1971港元,总金额约为970.17万港元。","market":"hk","thumbnail":"https://img.zhitongcaijing.com/image/20260119/20260119190838_98807.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260119/20260119190838_98807.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1394640.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["002821","06821","BK0132","BK1191","LU1328615791.USD","BK0239"],"gpt_icon":0},{"id":"2604597901","title":"股市必读:凯莱英(002821)1月16日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2604597901","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604597901?lang=zh_cn&edition=full","pubTime":"2026-01-19 01:28","pubTimestamp":1768757289,"startTime":"0","endTime":"0","summary":"截至2026年1月16日收盘,凯莱英报收于107.33元,上涨0.78%,换手率1.88%,成交量5.97万手,成交额6.39亿元。公司所服务的PPQ项目数量会随着公司所服务的项目进展,比如获批上市等情况动态变化。当日关注点来自交易信息汇总:1月16日主力资金净流出4067.55万元,游资资金净流入4069.08万元,呈现主力与游资反向操作态势。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011900000525.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1191","06821","BK0132","002821","BK0239","LU1328615791.USD"],"gpt_icon":0},{"id":"2603688509","title":"Schroders PLC减持凯莱英(06821)16.77万股 每股作价约83.63港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2603688509","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603688509?lang=zh_cn&edition=full","pubTime":"2026-01-13 18:53","pubTimestamp":1768301597,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,香港联交所最新资料显示,1月9日,Schroders PLC减持凯莱英(06821)16.77万股,每股作价83.6305港元,总金额约为1402.48万港元。减持后最新持股数目为550.56万股,最新持股比例为19.98%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1392307.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06821","002821","BK0239","BK0132","BK1191","LU1328615791.USD"],"gpt_icon":0},{"id":"2602553587","title":"凯莱英遭Schroders PLC减持26.05万股 每股作价约82.71港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2602553587","media":"新浪港股","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602553587?lang=zh_cn&edition=full","pubTime":"2026-01-11 16:29","pubTimestamp":1768120140,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n 香港联交所最新资料显示,1月7日,Schroders PLC减持凯莱英(06821)26.05万股,每股作价82.7099港元,总金额约为2154.59万港元。减持后最新持股数目为574.18万股,最新持股比例为20.84%。\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:卢昱君","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2026-01-11/doc-inhfxmcp3825365.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["06821","LU1328615791.USD","BK1191","BK0239","002821","BK0132"],"gpt_icon":0},{"id":"2602378543","title":"Schroders PLC减持凯莱英(06821)26.05万股 每股作价约82.71港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2602378543","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602378543?lang=zh_cn&edition=full","pubTime":"2026-01-09 19:30","pubTimestamp":1767958245,"startTime":"0","endTime":"0","summary":"香港联交所最新资料显示,1月7日,Schroders PLC减持凯莱英(06821)26.05万股,每股作价82.7099港元,总金额约为2154.59万港元。","market":"us","thumbnail":"https://img.zhitongcaijing.com/image/20260109/20260109193119_38417.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260109/20260109193119_38417.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1391112.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["LU1328615791.USD","BK1191","002821","06821","BK0132","BK0239"],"gpt_icon":0},{"id":"2601880356","title":"凯莱英(002821)披露证券变动月报表,1月5日股价上涨3.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601880356","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601880356?lang=zh_cn&edition=full","pubTime":"2026-01-05 22:45","pubTimestamp":1767624323,"startTime":"0","endTime":"0","summary":"截至2026年1月5日收盘,凯莱英报收于95.88元,较前一交易日上涨3.17%,最新总市值为345.74亿元。该股当日开盘93.2元,最高96.88元,最低93.04元,成交额达5.58亿元,换手率为1.84%。近日,凯莱英发布H股证券变动月报表公告。公告显示,截至2025年12月31日,公司H股和A股的法定/注册股本均无变动。H股已发行股份为27,553,260股,A股已发行股份为331,889,160股,库存股为1,151,300股。H股限制性股票计划项下本月底可能发行的股份为1,465,000股。公司呈交日期为2026年1月5日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010500040546.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002821","BK0132","06821","BK0239","LU1328615791.USD","BK1191","161027"],"gpt_icon":0},{"id":"2595972714","title":"凯莱英:多肽项目进入中后期后对产能需求高","url":"https://stock-news.laohu8.com/highlight/detail?id=2595972714","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595972714?lang=zh_cn&edition=full","pubTime":"2025-12-31 17:15","pubTimestamp":1767172517,"startTime":"0","endTime":"0","summary":"证券之星消息,凯莱英(002821)12月31日在投资者关系平台上答复投资者关心的问题。投资者提问:贵司多肽产能不断扩建已经要达到4万升了,但是贵司服务的核心多肽产品玛仕度肽订单被诺泰生物抢走了一些,贵司的多肽产能是否会面临着闲置的风险?凯莱英回复:尊敬的投资者,您好!多肽项目进入中后期后对产能需求高,目前公司在多肽减重领域共服务十几个分子, 近半数处于临床Ⅱ和Ⅲ期,预计明年部分项目将进入PPQ阶段,产能需求持续增加。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025123100030708.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002821","06821","BK0132","BK1191","LU1328615791.USD","BK0239"],"gpt_icon":0},{"id":"2595727110","title":"凯莱英:天津新产能匹配新业务领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2595727110","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595727110?lang=zh_cn&edition=full","pubTime":"2025-12-31 17:15","pubTimestamp":1767172517,"startTime":"0","endTime":"0","summary":"证券之星消息,凯莱英(002821)12月31日在投资者关系平台上答复投资者关心的问题。投资者提问:贵司天津小分子产能紧张,为何不能分流业务到敦化小分子基地生产?本来公司产能就闲置,为何还要重复建设产能?凯莱英回复:尊敬的投资者,您好!公司需要根据项目整体情况不同匹配最佳产能,以达到效益最大化。天津新产能主要匹配增速较快的新业务领域。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025123100030707.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1191","BK0239","002821","LU1328615791.USD","06821","BK0132"],"gpt_icon":0},{"id":"2594521497","title":"深市“双提升”:471家率先行动,分红占净利润比重2年提升近11个百分点","url":"https://stock-news.laohu8.com/highlight/detail?id=2594521497","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594521497?lang=zh_cn&edition=full","pubTime":"2025-12-27 11:01","pubTimestamp":1766804460,"startTime":"0","endTime":"0","summary":" 已有471家深市公司披露行动方案。 去年2月,深交所正式启动“质量回报双提升”专项行动,旨在推动全体上市公司夯实发展质量、增强投资价值回报能力。 市场反应积极正面,2024年2月至2025年11月,471家“双提升”公司股价平均涨幅77.2%,高于深证成指涨幅。截至2025年11月底,市值合计21.2万亿元,较专项行动启动前增长8.1万亿元,占深市总市值比重50.0%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2025-12-27/doc-inheezwv0075071.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-12-27/doc-inheezwv0075071.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1969619763.USD","LU0469268626.HKD","BK0060","BK0188","BK0196","300476","BK0231","LU2580892789.USD","LU2148510915.USD","LU0405327148.USD","300009","LU1328615791.USD","301095","000725","002594","LU1861214812.USD","IE0008368742.USD","002241","LU2289578879.USD","300760","002493","LU1655091616.SGD","EVS.SI","LU1508157978.USD","BK0132","LU1064130708.USD","300122","LU2348774022.SGD","LU2495084118.USD","BK0187","IE00B29SXG58.USD","LU0650527681.SGD","LU1734074674.USD","BK0197","IE00B031J352.USD","300919","002821","LU0594300419.USD","SGXZ49509284.SGD","LU1997245094.SGD","BK0070","LU0633140727.USD","BK0109","LU0823426480.USD","LU1242518857.USD","LU2663582299.SGD","BK0046","LU2153592121.USD","LU2348773727.SGD","BK0251"],"gpt_icon":0},{"id":"2593023432","title":"股市必读:凯莱英(002821)12月22日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2593023432","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593023432?lang=zh_cn&edition=full","pubTime":"2025-12-23 02:56","pubTimestamp":1766429772,"startTime":"0","endTime":"0","summary":"截至2025年12月22日收盘,凯莱英报收于94.7元,下跌0.09%,换手率1.24%,成交量3.93万手,成交额3.74亿元。董秘最新回复投资者: 尊敬的公司管理层:公司股价从高点回撤已30%有余,请问公司在维护市值方面有什么切实有效的措施?股票价格走势是波动变化的,受多种因素的综合影响,敬请广大投资者注意投资风险。交易信息汇总资金流向12月22日主力资金净流出274.28万元;游资资金净流入650.54万元;散户资金净流出376.27万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122300001504.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002821","BK0132","06821","LU1328615791.USD","BK1191","BK0239"],"gpt_icon":0},{"id":"2592167370","title":"凯莱英(06821)将购回及注销3.3万股受限制A股股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2592167370","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592167370?lang=zh_cn&edition=full","pubTime":"2025-12-19 21:30","pubTimestamp":1766151039,"startTime":"0","endTime":"0","summary":"智通财经APP讯,凯莱英(06821)发布公告,于2025年12月19日,本公司董事会审议并通过《关于回购注销2025年A股计划部分限制性股票的议案》,将购回及注销3.3万股由7名已离职合资格参与者根据2025年A股计划首次授予,以及一名已离职合资格参与者根据2025年A股计划预留授予项下所持有的已授出但尚未解禁的受限制A股股份(购回及注销事项)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1383989.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159982","002821","06821","399300","BK0132","BK1191","LU1328615791.USD","BK0239"],"gpt_icon":0},{"id":"2592345351","title":"医药股今早显著反弹 凯莱英及药明生物均涨超6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592345351","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592345351?lang=zh_cn&edition=full","pubTime":"2025-12-19 11:05","pubTimestamp":1766113500,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n 医药股今早明显反弹,CRO、创新药方向居前。截至发稿,凯莱英(06821)上涨6.07%,报76.85港元;药明生物(02269)上涨6.05%,报34.70港元;三生制药(01530)上涨4.65%,报26.58港元;诺诚健华(09969)上涨4.70%,报13.80港元。\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:卢昱君","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2025-12-19/doc-inhcicep7752391.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0417516902.SGD","LU0823426480.USD","BK1141","BK1161","BK1610","LU0588546209.SGD","LU0819121731.USD","LU0456846285.SGD","BK1515","LU0327786744.USD","LU0181495838.USD","LU0320764599.SGD","LU0051755006.USD","LU0052750758.USD","LU1328615791.USD","06821","LU0516423174.USD","SG9999002562.SGD","IE00B0JY6N72.USD","LU0708995583.HKD","SG9999002463.SGD","02269","LU0516422952.EUR","BK1589","BK1576","LU0359202008.SGD","LU0140636845.USD","LU1794554557.SGD","LU0516422366.SGD","LU0516423091.SGD","BK1521","09939","LU0359201612.USD","LU0572944931.SGD","LU0823426308.USD","LU1720050803.USD","BK0239","LU0039217434.USD","LU0456827905.SGD","LU0417516738.SGD","002821","BK1574","LU0979878070.USD","LU0348735423.USD","LU0856984785.SGD","LU3063872942.SGD","LU1688375341.USD","LU1242518857.USD","159938","LU0043850808.USD"],"gpt_icon":0},{"id":"2589383288","title":"港股异动 | 凯莱英(06821)午前涨近3% 近期凯莱英生物上海奉贤基地正式投产 重点布局联药物NDCs等领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2589383288","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589383288?lang=zh_cn&edition=full","pubTime":"2025-12-08 11:34","pubTimestamp":1765164854,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,凯莱英午前涨近3%,截至发稿,涨2.05%,报79.65港元,成交额1551.75万港元。消息面上,近期,据凯莱英官微消息,公司旗下凯莱英生物的上海奉贤商业化生产基地正式投产,该基地是凯莱英生物继上海金山基地和张江科学技术中心后重点打造的又一核心商业化产业基地,可助力客户快速推进商业化生产。奉贤基地商业化投产意味着凯莱英生物在生物药CDMO领域实现跨越式升级。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1378660.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","BK0239","LU1328615791.USD","06821","BK0132","002821"],"gpt_icon":0},{"id":"2588028059","title":"凯莱英(002821)披露A股股权激励股份转让进展,12月2日股价下跌2.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588028059","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588028059?lang=zh_cn&edition=full","pubTime":"2025-12-02 22:24","pubTimestamp":1764685492,"startTime":"0","endTime":"0","summary":"截至2025年12月2日收盘,凯莱英报收于92.6元,较前一交易日下跌2.06%,最新总市值为333.91亿元。公司近日发布公告称,截至2025年11月30日的证券变动月报表显示,凯莱英A股已发行股份增加291,400股,库存股相应减少291,400股,变动原因为2025年A股股权激励计划项下的库存股份转让。H股和A股的法定/注册股本均无变动,H股限制性股票计划下可能转让的股份为1,465,000股,H股库存股数量未发生变化。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120200039861.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002821","06821","399300","159982","BK0132","LU1328615791.USD","BK1191","BK0239"],"gpt_icon":0},{"id":"2586455247","title":"凯莱英(06821)授出29.14万股A股限制性股票","url":"https://stock-news.laohu8.com/highlight/detail?id=2586455247","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586455247?lang=zh_cn&edition=full","pubTime":"2025-11-27 19:29","pubTimestamp":1764242989,"startTime":"0","endTime":"0","summary":"智通财经APP讯,凯莱英(06821)发布公告,于2025年11月27日授出29.14万股A股限制性股票。更多港股重磅资讯,下载智通财经app更多港股及海外理财资讯,请点击www.zhitongcaijing.com(搜索“智通财经”);欲加入智通港股投资群,请加智通客服微信(ztcjkf)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1374661.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1191","159982","06821","LU1328615791.USD","399300","BK0239","BK0132","002821"],"gpt_icon":0},{"id":"2586107212","title":"凯莱英:持续技术创新保障业务增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2586107212","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586107212?lang=zh_cn&edition=full","pubTime":"2025-11-27 16:15","pubTimestamp":1764231322,"startTime":"0","endTime":"0","summary":"证券之星消息,凯莱英11月27日在投资者关系平台上答复投资者关心的问题。作为一家在创立伊始就将“技术驱动”作为企业核心竞争力的公司,凯莱英一贯重视技术创新和研发投入,持续保持对前沿技术的积极投入、探索与应用是保持CDMO产业稳健发展的关键。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112700019630.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1191","LU1328615791.USD","002821","BK0239","06821","BK0132"],"gpt_icon":0},{"id":"2584936667","title":"摩根大通减持凯莱英(06821)7.07万股 每股作价约84.7港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2584936667","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584936667?lang=zh_cn&edition=full","pubTime":"2025-11-18 18:42","pubTimestamp":1763462572,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,香港联交所最新资料显示,11月12日,摩根大通减持凯莱英(06821)7.07万股,每股作价84.704港元,总金额约为598.86万港元。减持后最新持股数目约为188.79万股,最新持股比例为6.85%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1370619.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4533","LU1280957306.USD","IE00BKDWB100.SGD","LU2023250330.USD","LU0976567544.SGD","IE00BLSP4239.USD","BK4585","IE00BZ1G4Q59.USD","IE00BLSP4452.SGD","LU0211326755.USD","IE00BJTD4V19.USD","LU2756315664.SGD","LU0868494708.USD","002821","BK4566","IE0034235188.USD","LU1551013425.SGD","LU1366192091.USD","LU0251132253.USD","LU2236285917.USD","LU0234572021.USD","LU0310799852.SGD","06821","LU1548497426.USD","BK0132","IE00BDRTCR15.USD","LU0689472784.USD","LU0820561909.HKD","LU0882574139.USD","LU2264538146.SGD","IE00B3S45H60.SGD","LU2746668461.USD","LU2023250504.SGD","LU0048584097.USD","LU0211331839.USD","LU1974910355.USD","BK4534","LU0787776722.HKD","LU2357305700.SGD","IE000M9KFDE8.USD","LU1670627923.USD","IE0034235303.USD","IE00BWXC8680.SGD","LU0211327993.USD","LU2237443895.HKD","IE00BDCRKT87.USD","BK4504","LU2211815571.USD","BK4516","LU1629891620.HKD"],"gpt_icon":0},{"id":"2583556496","title":"摩根大通增持凯莱英(06821)6.19万股 每股均价约83.89港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2583556496","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583556496?lang=zh_cn&edition=full","pubTime":"2025-11-13 18:58","pubTimestamp":1763031493,"startTime":"0","endTime":"0","summary":"香港联交所最新资料显示,11月10日,摩根大通增持凯莱英(06821)6.19万股,每股均价83.8905港元,总金额约为519.28万港元。","market":"us","thumbnail":"https://img.zhitongcaijing.com/image/20251113/20251113185845_63494.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20251113/20251113185845_63494.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1368927.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK4533","LU1280957306.USD","LU1162221912.USD","LU0976567544.SGD","LU2237443622.USD","BK4585","LU2462157665.USD","LU1116320737.USD","BK0239","LU0868494617.USD","LU1244550494.USD","LU0868494708.USD","002821","LU0256863811.USD","LU1032466523.USD","LU1366192091.USD","LU2054465674.USD","LU0211328371.USD","LU0310799852.SGD","IE00B1XK9C88.USD","06821","LU1119994496.HKD","LU2237443549.SGD","LU0496365809.HKD","IE00BDRTCR15.USD","LU0689472784.USD","LU0265550359.USD","LU0820561909.HKD","LU0640476718.USD","LU1670628061.USD","LU2023250504.SGD","LU0048584097.USD","LU2417539215.USD","LU0215105999.USD","LU1974910355.USD","LU2237443382.USD","BK4534","LU0964807845.USD","LU2237443978.SGD","LU2357305700.SGD","LU0070302665.USD","IE0034235303.USD","LU0238689110.USD","LU1894683348.USD","LU2237443895.HKD","IE00BYXW3230.USD","LU2211815571.USD","LU2213496289.HKD","LU0323591593.USD","BK4516"],"gpt_icon":0},{"id":"2582500363","title":"Norges Bank增持凯莱英(06821)6.52万股 每股作价约84.39港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2582500363","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582500363?lang=zh_cn&edition=full","pubTime":"2025-11-11 18:51","pubTimestamp":1762858283,"startTime":"0","endTime":"0","summary":"香港联交所最新资料显示,11月7日,Norges Bank增持凯莱英(06821)6.52万股,每股作价84.3896港元,总金额约为550.22万港元。","market":"sh","thumbnail":"https://img.zhitongcaijing.com/image/20251111/20251111185210_91310.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20251111/20251111185210_91310.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1367872.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["LU1328615791.USD","002821","BK1191","06821","BK0239","BK0132"],"gpt_icon":0},{"id":"2582118248","title":"凯莱英遭摩根大通减持20.2万股 每股作价约83.43港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2582118248","media":"新浪港股","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582118248?lang=zh_cn&edition=full","pubTime":"2025-11-10 07:49","pubTimestamp":1762732140,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n 香港联交所最新资料显示,11月4日,摩根大通减持凯莱英(06821)20.2万股,每股作价83.432港元,总金额约为1685.33万港元。减持后最新持股数目约为204.32万股,持股比例为7.41%。\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:卢昱君","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2025-11-10/doc-infwwmew9382427.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IE00BDCRKT87.USD","LU1496350171.SGD","LU0203347892.USD","LU2430703178.SGD","LU2430703251.USD","LU2236285917.USD","SG9999002232.USD","LU0234572021.USD","LU1988902786.USD","LU2264538146.SGD","LU2746668461.USD","IE0034235295.USD","LU0211327993.USD","002821","LU1551013425.SGD","LU2023250843.SGD","IE00BYXW3230.USD","LU1162221912.USD","BK4516","LU0345769128.USD","IE00BDRTCR15.USD","SG9999002224.SGD","LU0320765489.SGD","BK4533","BK4581","LU1366192091.USD","BK4504","BK4534","LU0345770993.USD","LU2505996681.GBP","LU0943347566.SGD","LU2592432038.USD","BK4207","IE00B775SV38.USD","BK4588","IE00B1XK9C88.USD","IE00B1BXHZ80.USD","LU2430703095.HKD","LU0170899867.USD","LU2106854487.HKD","LU2211815571.USD","IE0034235303.USD","LU2237443382.USD","LU1668664300.SGD","LU2417539215.USD","LU0683600562.USD","LU0345769631.USD","LU2456880835.USD","LU1280957306.USD","06821"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1768955509082,"stockEarnings":[{"period":"1week","weight":-0.0252},{"period":"1month","weight":0.0887},{"period":"3month","weight":-0.0219},{"period":"6month","weight":-0.0884},{"period":"1year","weight":0.3843},{"period":"ytd","weight":0.1105}],"compareEarnings":[{"period":"1week","weight":-0.0061},{"period":"1month","weight":0.0574},{"period":"3month","weight":0.0511},{"period":"6month","weight":0.1409},{"period":"1year","weight":0.2679},{"period":"ytd","weight":0.0365}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"凯莱英医药集团(天津)股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"0人","perCapita":"--","listingDate":"2016-11-18","address":"天津市滨海新区经济技术开发区洞庭三街6号","registeredCapital":"36059万元","survey":" 凯莱英医药集团(天津)股份有限公司的主营业务是为国内外制药公司、生物技术公司提供药品全生命周期的一站式服务。公司的主要产品是临床阶段CDMO解决方案、商业化阶段CDMO解决方案、新兴服务。截至报告期末公司共有国内外已授权专利538项,其中国内专利423项,国外专利115项,其中183项在合成生物领域,204项在连续反应技术领域。","listedPrice":30.53},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"凯莱英(002821)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供凯莱英(002821)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"凯莱英,002821,凯莱英股票,凯莱英股票老虎,凯莱英股票老虎国际,凯莱英行情,凯莱英股票行情,凯莱英股价,凯莱英股市,凯莱英股票价格,凯莱英股票交易,凯莱英股票购买,凯莱英股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"凯莱英(002821)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供凯莱英(002821)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}